These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4087135)

  • 41. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.
    Poulin P
    J Pharm Sci; 2015 Jun; 104(6):2110-2118. PubMed ID: 25808270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up.
    Mitsuhashi Y; Sugiyama Y; Ozawa S; Nitanai T; Sasahara K; Nakamura K; Tanaka M; Nishimura T; Inaba M; Kobayashi T
    Cancer Chemother Pharmacol; 1990; 27(1):20-6. PubMed ID: 2245489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of milk/plasma concentration ratio of drugs.
    Larsen LA; Ito S; Koren G
    Ann Pharmacother; 2003 Sep; 37(9):1299-306. PubMed ID: 12921514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the distribution of drugs in saliva and blood plasma.
    Feller K; le Petit G
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human.
    Kawai R; Mathew D; Tanaka C; Rowland M
    J Pharmacol Exp Ther; 1998 Nov; 287(2):457-68. PubMed ID: 9808668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
    Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
    Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability.
    Ruark CD; Hack CE; Robinson PJ; Mahle DA; Gearhart JM
    J Pharm Sci; 2014 Jul; 103(7):2189-2198. PubMed ID: 24832575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    Drug Metab Dispos; 1985; 13(1):102-6. PubMed ID: 2858365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of minipigs for predicting human pharmacokinetics: Prediction of distribution volume and plasma clearance.
    Yoshimatsu H; Konno Y; Ishii K; Satsukawa M; Yamashita S
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):73-81. PubMed ID: 26776246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of disposition parameters of quinidine and quinine in the rat.
    Watari N; Wakamatsu A; Kaneniwa N
    J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered drug-serum protein binding in the genetically obese Zucker rat.
    Benedek IH; Blouin RA; McNamara PJ
    J Pharm Sci; 1985 Aug; 74(8):837-40. PubMed ID: 4032266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes.
    Yin J; Qiu H; Dai J; Lu Y; Zhao R; Chen L; Meng Q
    Can J Physiol Pharmacol; 2013 Feb; 91(2):178-86. PubMed ID: 23458203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.